<DOC>
	<DOCNO>NCT02131753</DOCNO>
	<brief_summary>The trial test effectiveness toxicity subcutaneous treatment one cycle cladribine patient hairy cell leukemia require treatment . They untreated far may pretreated alpha-interferon .</brief_summary>
	<brief_title>Therapy Optimisation Treatment Hairy Cell Leukemia</brief_title>
	<detailed_description>Evaluation remission status take place 4 month treatment . In addition , test whether patient non-optimal response benefit second cycle cladribine . Non-optimal response : patient detectable residual disease ; achievement partial remission detectable residual infiltration bone marrow .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Hairy Cell</mesh_term>
	<mesh_term>Cladribine</mesh_term>
	<criteria>Patients histologically verify hairy cell leukemia Presence hairy cell bone marrow peripheral blood detect positive TRAP stain / co expression cell surface antigens cluster differentiation ( CD ) 19/CD25 CD19/CD103 ( bly7 ) No previous cytostatic treatment ( splenectomy interferon treatment allow ) Need treatment Age least 18 year old General state health accord WHO 02 Current histology , old 6 month Written consent patient Patients fulfil inclusion criterion Hairy cell leukemia variant ( HCLV ) : presence lymphoid cell bone marrow / peripheral blood , intermediate morphology hairy cell prolymphocytes ( negative TRAP stain co expression CD19/CD103 without CD25 Pretreatment purine analogue chemotherapeutics Concomitant corticosteroid therapy Severe dysfunction heart ( NYHA III IV ) , lung ( WHOGrade III IV ) , liver , except due lymphoma ( bilirubin &gt; 2 mg/dl , alkaline phosphatase , glutamateoxalacetate transaminase glutamatepyruvate transaminase &gt; 2 x upper limit normal ) , kidney ( creatinin &gt; 2 mg/dl creatinine clearance &lt; 50 ml/min ) , central nervous system diseases include psychosis . Proven HIV infection Active Hepatitis Other florid infection Anamnesis / diagnosis malignant disease ( nonmelanoma associate skin tumour stage 0 situ carcinoma cervix ) Pregnant lactate woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>hairy cell leukemia</keyword>
	<keyword>untreated</keyword>
	<keyword>cladribine subcutaneous</keyword>
</DOC>